These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 10190313)
1. The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells. He P; Tang ZY; Liu BB; Ye SL; Liu YK J Cancer Res Clin Oncol; 1999; 125(2):77-82. PubMed ID: 10190313 [TBL] [Abstract][Full Text] [Related]
2. The targeted expression of interleukin-2 in human hepatocellular carcinoma cells. He P; Tang ZY; Ye SL; Liu BB; Liu YK J Exp Clin Cancer Res; 2000 Jun; 19(2):183-7. PubMed ID: 10965816 [TBL] [Abstract][Full Text] [Related]
3. A novel approach for inducing enhanced and selective transgene expression in hepatocellular-carcinoma cells. Cao G; Kuriyama S; Tsujinoue H; Chen Q; Mitoro A; Qi Z Int J Cancer; 2000 Jul; 87(2):247-52. PubMed ID: 10861483 [TBL] [Abstract][Full Text] [Related]
4. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter. Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481 [TBL] [Abstract][Full Text] [Related]
5. Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma. Pin RH; Reinblatt M; Fong Y Ann Surg; 2004 Oct; 240(4):659-65; discussion 665-6. PubMed ID: 15383793 [TBL] [Abstract][Full Text] [Related]
6. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter. Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049 [TBL] [Abstract][Full Text] [Related]
7. Assessment of α-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging. Park JH; Kim KI; Lee KC; Lee YJ; Lee TS; Chung WS; Lim SM; Kang JH Cancer Biother Radiopharm; 2015 Feb; 30(1):8-15. PubMed ID: 25545853 [TBL] [Abstract][Full Text] [Related]
8. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter. Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430 [TBL] [Abstract][Full Text] [Related]
9. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells. Mao C; Liu H; Chen P; Ye J; Teng L; Jia Z; Cao J Oncotarget; 2015 Mar; 6(8):5707-19. PubMed ID: 25691059 [TBL] [Abstract][Full Text] [Related]
10. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma. Ma XJ; Huang R; Kuang AR Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter. Cao G; Kuriyama S; Gao J; Nakatani T; Chen Q; Yoshiji H; Zhao L; Kojima H; Dong Y; Fukui H; Hou J Eur J Cancer; 2001 Jan; 37(1):140-7. PubMed ID: 11165141 [TBL] [Abstract][Full Text] [Related]
12. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene. Su H; Chang JC; Xu SM; Kan YW Hum Gene Ther; 1996 Mar; 7(4):463-70. PubMed ID: 8800740 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712 [TBL] [Abstract][Full Text] [Related]
14. Differential regulation of albumin gene expression by heparin-binding epidermal growth factor-like growth factor in alpha-fetoprotein-producing and -nonproducing human hepatoma cells. Ishikawa H; Nakata K; Tsuruta S; Nakao K; Kato Y; Tamaoki T; Eguchi K Tumour Biol; 1999; 20(3):130-8. PubMed ID: 10213920 [TBL] [Abstract][Full Text] [Related]
15. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences. Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990 [TBL] [Abstract][Full Text] [Related]
16. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663 [TBL] [Abstract][Full Text] [Related]
17. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter. Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409 [TBL] [Abstract][Full Text] [Related]